Here's How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 15 Years

Regeneron Pharmaceuticals REGN has outperformed the market over the past 15 years by 12.37% on an annualized basis producing an average annual return of 24.38%. Currently, Regeneron Pharmaceuticals has a market capitalization of $74.02 billion.

Buying $100 In REGN: If an investor had bought $100 of REGN stock 15 years ago, it would be worth $2,562.19 today based on a price of $673.60 for REGN at the time of writing.

Regeneron Pharmaceuticals's Performance Over Last 15 Years

Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.

This article was generated by Benzinga's automated content engine and reviewed by an editor.